News > Panacea Biotec to make 100 m doses of Sputnik V vaccine
Panacea Biotec to make 100 m doses of Sputnik V vaccine
The Hindu | 05/04/2021 11:15 PM | Click to read full article
Vaccine and pharma major Panacea Biotec has joined a growing list of Indian firms cleared to produce Sputnik V, the Russian vaccine against COVID-19.
The firm will produce 100 million doses per year of Sputnik V, Russia’s sovereign wealth fund RDIF (Russian Direct Investment Fund) said on Monday, announcing its fifth such partnership with vaccine makers in India.
